715 related articles for article (PubMed ID: 7380201)
1. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N
Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201
[TBL] [Abstract][Full Text] [Related]
2. Minimal bile acid malabsorption and normal bile acid breath tests in cystic fibrosis and acquired pancreatic insufficiency.
Roller RJ; Kern F
Gastroenterology; 1977 Apr; 72(4 Pt 1):661-5. PubMed ID: 838220
[TBL] [Abstract][Full Text] [Related]
3. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
[TBL] [Abstract][Full Text] [Related]
5. Reduced intraluminal bile acid concentrations and fat maldigestion in pancreatic insufficiency: correction by treatment.
Regan PT; Malagelada JR; Dimagno EP; Go VL
Gastroenterology; 1979 Aug; 77(2):285-9. PubMed ID: 447041
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
Ansaldi-Balocco N; Santini B; Sarchi C
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
[TBL] [Abstract][Full Text] [Related]
7. Cimetidine and fat malabsorption in children with cystic fibrosis.
Schöni M; Kraemer R; Rossi E
Helv Paediatr Acta; 1981 Sep; 36(4):359-69. PubMed ID: 7024207
[TBL] [Abstract][Full Text] [Related]
8. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
[TBL] [Abstract][Full Text] [Related]
9. The effect of cimetidine on meal-stimulated gastric function and exogenous pancreatic enzymes in cystic fibrosis.
Cameron DJ; Pitcher-Wilmott R; Milla PJ; More J; Ghale GK; Matthew DJ; Harries JT
Hum Nutr Clin Nutr; 1982; 36(6):475-81. PubMed ID: 6925576
[TBL] [Abstract][Full Text] [Related]
10. Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.
Durie PR; Bell L; Linton W; Corey ML; Forstner GG
Gut; 1980 Sep; 21(9):778-86. PubMed ID: 7429342
[TBL] [Abstract][Full Text] [Related]
11. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events.
Bijvelds MJ; Bronsveld I; Havinga R; Sinaasappel M; de Jonge HR; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G646-53. PubMed ID: 15528257
[TBL] [Abstract][Full Text] [Related]
12. The effect of cimetidine on maldigestion in cystic fibrosis.
Cox KL; Isenberg JN; Osher AB; Dooley RR
J Pediatr; 1979 Mar; 94(3):488-92. PubMed ID: 423042
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosis.
Chazalette JP; Dain MP; Castaigne JP
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S46-8. PubMed ID: 3042939
[TBL] [Abstract][Full Text] [Related]
14. Taurine improves the absorption of a fat meal in patients with cystic fibrosis.
Belli DC; Levy E; Darling P; Leroy C; Lepage G; Giguère R; Roy CC
Pediatrics; 1987 Oct; 80(4):517-23. PubMed ID: 3658570
[TBL] [Abstract][Full Text] [Related]
15. Effect of taurine supplements on growth, fat absorption and bile acid on cystic fibrosis.
Carrasco S; Codoceo R; Prieto G; Lama R; Polanco I
Acta Univ Carol Med (Praha); 1990; 36(1-4):152-6. PubMed ID: 2130680
[TBL] [Abstract][Full Text] [Related]
16. Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes.
Roy CC; Weber AM; Morin CL; Combes JC; Nusslé D; Mégevand A; Lasalle R
N Engl J Med; 1977 Dec; 297(24):1301-5. PubMed ID: 917086
[TBL] [Abstract][Full Text] [Related]
17. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
[TBL] [Abstract][Full Text] [Related]
18. Fecal excretion of bile acids: a new technique for studying bile acid kinetics in patients with ileal resection.
Woodbury JF; Kern F
J Clin Invest; 1971 Dec; 50(12):2531-40. PubMed ID: 5129306
[TBL] [Abstract][Full Text] [Related]
19. Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis.
Laiho KM; Gavin J; Murphy JL; Connett GJ; Wootton SA
Clin Nutr; 2004 Jun; 23(3):347-53. PubMed ID: 15158298
[TBL] [Abstract][Full Text] [Related]
20. Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis.
Zentler-Munro PL; Fine DR; Batten JC; Northfield TC
Gut; 1985 Sep; 26(9):892-901. PubMed ID: 3849459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
